Harnessing the Body’s Natural Mechanisms: Aphaia Pharma’s Novel Approach to Metabolic Disease TreatmentPrevious pageHow Digital Endpoints Are Redefining Clinical Research Strategies: Insights from DiMeNext pageContents Page